X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

FENC

Closed

Fennec Pharmaceuticals Inc

8.3
0.0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 8.3
Day's Range: 8.28 - 8.4837
Send
When Written:
 
8.32
Fennec Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of cancer treatments. The company's lead product candidate is called PEDMARK, which is a formulation of sodium thiosulfate that is designed to reduce the incidence and severity of ototoxicity (hearing loss) associated with platinum-based chemotherapy in children. PEDMARK has been granted Breakthrough Therapy designation by the US FDA and is currently undergoing Phase III clinical trials. Fennec Pharmaceuticals Inc was founded in 1996 and is headquartered in Durham, North Carolina. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol FENC.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X